Senior insider sale
EVP & Chief Financial Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$630.0K
62.50K shares
What this filing means
O'BYRNE JASON plans to sell 62.50K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $630.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/25/2026ACC: 0001959173-26-006425
Officer· EVP & Chief Financial Officer
Since Feb 2026
62.50K
Shares to sell
$630.0K
Approx. market value
23.15K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/25/2026
23.15KTotal acquired23.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/25/2026 | Stock Option Exercise Cash | 23.15K | — |
| Total | 23.15K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
14.35K
Market value
$142.1K
8/24/2026
—Completed
Units to sell
25K
Market value
$245.3K
8/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
23.15K
Market value
$242.6K
8/25/2026
Total
Units
62.50K
Value
$630.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/24/2026 | 14.35K | $142.1K | — | Completed |
8/21/2026 | 25K | $245.3K | — | Completed |
| Planned — Approximate Date | ||||
8/25/2026 | 23.15K | $242.6K | NASDAQ | Planned |
| Total | 62.50K | $630.0K | ||